These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35255552)

  • 1. Myocardial Infarction, Stroke, and All-Cause Mortality according to Low-Density Lipoprotein Cholesterol Level in the Elderly, a Nationwide Study.
    Lee YB; Koo M; Noh E; Hwang SY; Kim JA; Roh E; Hong SH; Choi KM; Baik SH; Cho GJ; Yoo HJ
    Diabetes Metab J; 2022 Sep; 46(5):722-732. PubMed ID: 35255552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Schubert J; Lindahl B; Melhus H; Renlund H; Leosdottir M; Yari A; Ueda P; James S; Reading SR; Dluzniewski PJ; Hamer AW; Jernberg T; Hagström E
    Eur Heart J; 2021 Jan; 42(3):243-252. PubMed ID: 33367526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate's impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study.
    Hong S; Kim KS; Han K; Park CY
    Cardiovasc Diabetol; 2024 Jul; 23(1):263. PubMed ID: 39026240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Tanner RM; Colantonio LD; Kilgore ML; Mefford MT; Chachappan DT; Mues KE; Safford MM; Rosenson RS; Muntner P
    J Clin Lipidol; 2020; 14(5):720-729. PubMed ID: 32680814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on all-cause mortality at different low-density-lipoprotein cholesterol levels in Asian patients with type 2 diabetes.
    Chen PH; Wang JS; Lin SY; Li CH; Wang CY; Hu CY; Fu CP; Tsai YT; Lee AT; Chen YW; Li YH; Lee CL
    Curr Med Res Opin; 2018 Nov; 34(11):1885-1892. PubMed ID: 29429368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy in individuals with intermediate cardiovascular risk.
    Kim J; Kim H; Park SH; Kang Y; Han K; Lee SH
    Metabolism; 2024 Jan; 150():155723. PubMed ID: 37926200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study.
    Lee YB; Kim MY; Han K; Kim B; Park J; Kim G; Hur KY; Kim JH; Jin SM
    Sci Rep; 2022 Nov; 12(1):19383. PubMed ID: 36371594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. J-shaped association between LDL cholesterol and cardiovascular events: A longitudinal primary prevention cohort of over 2.4 million people nationwide.
    Park CS; Yang HM; Han K; Lee HS; Kang J; Han JK; Park KW; Kang HJ; Koo BK; Kim HS
    J Adv Res; 2024 Apr; 58():139-147. PubMed ID: 37225014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between low-density lipoprotein cholesterol and cardiovascular mortality in statin non-users: a prospective cohort study in 14.9 million Korean adults.
    Yi SW; An SJ; Park HB; Yi JJ; Ohrr H
    Int J Epidemiol; 2022 Aug; 51(4):1178-1189. PubMed ID: 35218344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Moderately but Persistently Elevated Lipid Levels on Risks of Stroke and Myocardial Infarction in Young Korean Adults.
    Park JB; Kim DH; Lee H; Lee HJ; Hwang IC; Yoon YE; Park HE; Lee SP; Choi SY; Kim YJ; Cho GY; Han K; Kim HK
    J Am Heart Assoc; 2021 Jun; 10(12):e020050. PubMed ID: 34056926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Treatment in Patients With Stroke With Low-Density Lipoprotein Cholesterol Levels Below 70 mg/dL.
    Kim JT; Lee JS; Kim BJ; Kang J; Lee KJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Lee K; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Yum KS; Sohn SI; Hong JH; Lee SH; Park MS; Choi KH; Lee J; Park KY; Bae HJ
    J Am Heart Assoc; 2023 Sep; 12(18):e030738. PubMed ID: 37681519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
    Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
    Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study.
    Lee CJ; Park S; Han K; Lee SH
    J Am Heart Assoc; 2022 May; 11(9):e024379. PubMed ID: 35470675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
    Johannesen CDL; Mortensen MB; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2021 Mar; 77(11):1439-1450. PubMed ID: 33736827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.
    Jafri H; Alsheikh-Ali AA; Karas RH
    Ann Intern Med; 2010 Dec; 153(12):800-8. PubMed ID: 21173414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting.
    Hasvold P; Thuresson M; Sundström J; Hammar N; Kjeldsen SE; Johansson G; Holme I; Bodegård J
    Clin Drug Investig; 2016 Mar; 36(3):225-33. PubMed ID: 26718960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.